Welcome to wchemv
|
Foshan Xinhang Biological Technology Co., Ltd.
Foshan Xinhang Biological Technology Co., Ltd.
Sign in or Join Free Now!

Contact Us

Street Address
No. 1617, Greenland Commercial Center, No. 286, Dongle Road, Community Residents Committee, Daliang District, Shunde District, Foshan City
Country/Region
China/guangdong
Telephone

--

Tranexamic acid
Tranexamic acid
Supply Ability:
11111111 Kilogram/Kilograms per 0
Port:
hk
Email:
Quantity:
Kilogram
 Message:
  • Product Details
  • Company Profile
Quick Details
Place of Origin:
China
Brand Name:
Model Number:
Packaging & Delivery
CAS: 1197-18-8
MF: C8H15NO2
MW: 157.21
EINECS: 214-818-2
Product Description

morgan@chembj.com,

whatapp:+86 17725670492

Tranexamic acid


Alias: Amstat

Synonym: TIMTEC-BB SBB006715; TRANS-4-AMINOMETHYL-1-CYCLOHEXANECARBOXYLIC ACID; Trans-4-aminomethylcyclohexane-1-carboxylate; TRANS-4-(AMINOMETHYL)CYCLOHEXANECARBOXYLIC ACID; TRANEXAMIC ACID; Amstat; Amcha; Amikapron

CAS: 1197-18-8

MF: C8H15NO2

MW: 157.21

EINECS: 214-818-2

Assay: 99%

Specification: CP

Appearance: White powder

Chemical Property: To aminomethylbenzoic acid tranexamic acid derivatives, is a kind of antifibrinolytic drugs to stop bleeding, hemostasis and aminocaproic acid, tranexamic acid, but the effect is stronger, strength is 7 ~ 2 amino acid 10 times, aminomethylbenzoic acid, and similar in toxicity.


Description:

Tranexamic acid is a synthetic derivative of the amino acid lysine.Tranexamic acid (commonly marketed in tablet form as Lysteda and in IV form as Cyklokapron in the U.S. and as Transamin,Transcam in Asia, and Espercil in South America) is often prescribed for excessive bleeding.

 

Tranexamic acid is an antifibrinolytic that competitively inhibits the activation of plasminogen to plasmin, a molecule responsible for the degradation of fibrin. Fibrin is the basic framework for the formation of a blood clot in hemostasis.Tranexamic acid has roughly 8 times the antifibrinolytic activity of an older analogue, ε-aminocaproic acid.


Usage:

1. Hemostatic, significant effect on traumatic bleeding, preoperative prophylactic medication can decrease operation hemorrhage.

2. The chemical structure of tranexamic acid and lysine, competitive inhibition of plasminogen to fibrin adsorption, to prevent their activation, protect the fiber protein was not degraded by the enzyme and dissolved, ultimately achieve hemostasis effect.

3. All applicable in the treatment of acute or chronic, localized or systemic primary fibrinolysis hyperfunction caused by bleeding, such as obstetric hemorrhage, renal hemorrhage, hypertrophy of the prostate, hemophilia hemorrhage, pulmonary tuberculosis hemoptysis, bleeding in the stomach, liver, lung, spleen and other organs of hemorrhage after operation

4. The clinical effect of tranexamic acid on insect bites, eczema and dermatitis, simple purpura, chronic urticaria, artificial sex urticaria, rash and drug poisoning effect, also have certain effects on erythroderma, scleroderma, SLE, erythema multiforme, herpes zoster and alopecia areata, curative effect of hereditary angioedema is also good.


Send your message to this manufacturer
Email:
Message:
Your message must be between 20-8000 characters